NYSE: $TAK A New Chapter in Blood Disorder Management For patients living with Polycythemia Vera (PV), managing hematocrit levels and the risks of blood clots has long been a challenging daily reality. Recently, the medical landscape for this chronic condition saw a significant shift with the FDA approval of Mimrylo (rusfertide). Understanding Mimrylo Mimrylo is…